武漢凡谷(002194.SZ):目前公司未涉及CPO相關產品和技術
格隆匯5月10日丨武漢凡谷(002194.SZ)在投資者互動平台表示,公司產業投資基金平潭華業聚焦二號股權投資合夥企業(有限合夥)及其子基金長沙華業高創私募股權基金合夥企業(有限合夥)合計持有武漢敏芯的股權比例非常小,上述投資不會對公司本年度的財務狀況和經營成果產生重大影響。該投資不屬於公司法定信息披露的範疇。關於武漢敏芯的相關情況詳見其官網公開信息。另外,目前公司未涉及CPO相關產品和技術,但公司可以提供光器件所用的陶瓷封裝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.